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Genetic Polymorphism and 
Alcohol Metabolism
Subodh Kumar Jain, Sapna Sedha and Meeta Mishra
Abstract
Throughout the world, human population experiment with alcohol, result into 
short- and long-term consequences including increased risk of accidental injuries, 
risky sexual behavior and lower education attainment. Due to polymorphism in the 
gene whose product enzymes are responsible for alcohol metabolism, serious health 
consequences including liver cirrhosis and hepatocarcinoma can occur. Enzyme 
alcohol dehydrogenase, CYP450 and catalase are alcohol metabolizing enzymes. 
Polymorphism in any one or all of the enzymes will result in defective alcohol 
metabolism and acetaldehyde accumulation cause serious health problems. This 
article mainly focuses on the consequences of alcohol consumption at genetic level 
that ultimately affect alcohol metabolism resulting in various health disorders.
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1. Introduction
Alcohol abuse and alcoholism represent substantial problems that affect a large 
portion of individuals throughout the world. More than 200 disease and injury 
conditions are caused by alcohol consumption due to liver cirrhosis, cancer and 
various injuries [1]. According to Organization for Economic Cooperation and 
Development (OECD) report released in May 2015, alcoholism has been increased 
by about 55% between 1992 and 2012. It is a quickly rising concern among the youth 
of the country. According to WHO [2], alcohol per capita consumption increased 
in China and India (China: 4.1, 7.1 and 7.2 liters in 2005, 2010 and 2016 respectively; 
India: 2.4, 4.3 and 5.7 liters in 2005, 2010 and 2016 respectively). By 2025, the 
highest increase in per capita alcohol consumption is expected in India and China 
covering largest population of South-East Asia and Western Pacific region. Table 1 
indicates Indian scenario of alcohol consumption.
Approximately 80% of the college students consume alcohol which can have 
short- and long-term consequences including increased risk of accidental injury, 
risky sexual behavior, and lower education attainment. Alcohol use stimulates 
the Hypothalamic-Pituitary-Adrenal (HPA) axis and causes stress-like cortisol 
responses [3, 4]. Frequent stimulation of the HPA by alcohol may alter the func-
tion of the system, setting the stage for reduced activity to stressors and increased 
likelihood of alcohol use disorder. Moreover, abnormal stress physiology is related 
to greater addiction severity, cravings, and poor treatment outcome alcohol use 
disorder [5]. More than 90% of people who drink heavily develop fatty liver, a type 
of liver disease. Yet only 20% will go on to develop the more severe alcoholic liver 
disease and liver cirrhosis [6]. Environmental factors and genetic differences in the 
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way alcohol is metabolized, also contribute to the development of alcoholic pancre-
atitis [8]. Genetic factors, for example, variation in enzyme activity that metabolize 
alcohol and environmental factors, for example, quantity of alcohol and overall 
nutrition a person consume play an important role in the etiology of alcoholic 
liver disorders including liver cancer. It has been reported that in the population 
of Central India who consume alcohol are at risk for liver disorders due to ALDH2, 
GSTM1 and GSTT1 gene polymorphism [9, 10].
This article mainly focuses on the consequences of alcohol consumption at 
genetic level that ultimately affect alcohol metabolism resulting in various health 
disorders.
2. Alcohol types and components
There are two categories of alcoholic beverages, fermented (beer and wine) and 
distilled (whiskey, rum, gin, vodka etc.) and the concentration of ethanol differs 
across preparation. Yeast fermented alcoholic drinks generally contain less concen-
tration of alcohol since yeast stops growing at about 15% ethanol concentration 
while strong alcoholic drinks/liquors are prepared through distillation [11].
State/UT Toddy and 
country 
liquor (ml)
Beer, imported 
alcohol, wine 
(ml)
State/UT Toddy and 
country 
liquor (ml)
Beer, imported 
alcohol, wine 
(ml)
Andaman and 
Nicobar Island
656 532 Lakshadweep 0 0
Andhra Pradesh 561 104 Madhya Pradesh 133 12
Arunachal 
Pradesh
749 346 Maharashtra 65 19
Assam 304 19 Manipur 155 6
Bihar 266 17 Meghalaya 74 49
Chandigarh 37 42 Mizoram 29 2
Chhattisgarh 120 27 Nagaland 159 23
Dadra and 
Nagar Haveli
2533 498 Orissa 146 20
Daman and Diu 252 1079 Pondicherry 154 144
Delhi 55 86 Punjab 141 50
Goa 47 108 Rajasthan 80 43
Gujarat 53 3 Sikkim 41 307
Haryana 89 43 Tamil Nadu 20 85
Himachal 
Pradesh
149 73 Tripura 163 2
Jammu and 
Kashmir
32 7 Uttar Pradesh 34 5
Jharkhand 320 14 Uttarakhand 38 43
Karnataka 23 102 West Bengal 74 12
Kerala 94 102
Table 1. 
State-wise alcohol consumption per capita per week in India [7].
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Most alcoholic beverages mainly contain ethanol and water. Some beverages 
like beer, wine, spirit contain volatile and non-volatile substances along with 
ethanol. Volatile compounds include hydrocarbons, aliphatic carbon compounds, 
monocarboxylic acids esters, compounds having sulfur and nitrogen, benzene 
etc. Dibasic carboxylic acids, tribasic carboxylic acids, coloring agents, inor-
ganic salts polyphenols, tannic acid etc. are the non-volatile substances [12]. 
Contaminants and toxins found are nitrosamines, mycotoxins, ethyl carbamate, 
pesticides, thermal processing contaminants, benzene, and inorganic contami-
nants include lead, cadmium, arsenic, copper, chromium, inorganic anions, and 
organometals [12].
Regardless of how much a person consume, the body can only metabolize a 
certain amount of alcohol every hour. That amount varies widely among individuals 
and depending on liver size and body mass [13]. The effects of alcohol on vari-
ous tissues depend on blood alcohol concentration (BAC) over time. The time of 
alcohol absorption, distribution, metabolism and excretion determines BAC [14]. 
After absorption from small intestine, alcohol reaches liver for metabolism. The 
rate of BAC rise depends on how quickly alcohol is emptied from the stomach and 
its metabolism during first pass through stomach and liver [15, 16]. BAC depends 
on various factors viz. the presence of food in the stomach, alcoholic beverages, 
the rate of alcohol drinking and genetic polymorphism of alcohol dehydrogenase 
(ADH) and aldehyde dehydrogenase (ALDH). Depending upon age, diet, alcohol 
consumption and smoking, the rate of alcohol elimination varies from individual to 
individual [17].
In the developing world, alcohol use is one of the prevalent habit and is respon-
sible for liver cancer [18–20]. Heavy drinking along with smoking increase the risk 
of developing cancers [21]. Observations suggest that some people develop cancer 
even at moderate daily alcohol consumption indicating that alcohol metabolism is 
genetically determined [22]. Also, those who typically consumed more than two 
drinks per drinking day were at increased risk of high blood pressure, high triglyc-
erides, increased abdominal girth, and elevated blood glucose. Further, excessive 
per-occasion consumption is the primary risk factor for both acute and chronic 
alcohol-related problems [23].
3. Alcohol metabolism
The pharmacologic and potentially pathologic effects of alcohol depend on 
the concentration of ethanol and its metabolites in the body, and on the duration 
of exposure to these substances. Alcohol is metabolized in the body by various 
mechanisms, that is, oxidative pathways involving alcohol dehydrogenase (ADH), 
aldehyde dehydrogenase (ALDH), cytochrome P450, and catalase enzymes (which 
either add oxygen or remove hydrogen) and non-oxidative pathways.
4. Oxidative metabolism
Most of the alcohol that people drink is metabolized in the liver. First, alcohol is 
oxidized to acetaldehyde by alcohol dehydrogenase (ADH). Acetaldehyde is highly 
toxic to the body, even in low concentrations. In the second step, acetaldehyde is 
further metabolized by ALDH to acetate and eventually to acetyl CoA, which then 
is broken down into water and carbon dioxide for easy elimination (Figure 1). Thus 
depending on the nutritional, hormonal, energetic status, the acetyl CoA is con-
verted to CO2, ketone bodies, fatty acid and Cholesterol [14].
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5. Byproducts of oxidative metabolism
5.1 Acetaldehyde
Acetaldehyde has the power to cause tremendous damage regardless of its short life. 
This is particularly evident in the liver, where major alcohol metabolism occurs [17]. 
Minor alcohol metabolism also takes place in the pancreas [24] and the brain, causing 
damage to cells and tissues [13]. Additionally, small amount of alcohol is metabolized 
to acetaldehyde in the gastrointestinal tract, exposing it to damaging effects [22]. The 
International Agency for Research on Cancer [25] asserts that acetaldehyde should be 
classified as a carcinogen, it promotes cancer in several ways, for example, by interfer-
ing with replication of DNA and by inhibiting a process by which the body repairs 
damaged DNA [22]. Studies have shown that people who are exposed to large amounts 
of acetaldehyde are at greater risk for developing cancer of the mouth and throat [22].
Acetaldehyde possesses the ability to bind to various proteins like enzymes, 
microsomal proteins and microtubules. It combines with neurotransmitter 
dopamine and form salsolinol that cause alcohol dependence and also form DNA 
adducts, for example, 1,N2-propanodeoxyguanosine which is carcinogenic [17]. 
However it is also reported that acetaldehyde concentrations in the brain are not 
high enough to produce these effects [26]. This is because the brain has a unique 
blood–brain barrier, which protects it from toxic products circulating in the blood-
stream. However, it is possible that due to alcohol metabolism, acetaldehyde is 
produced in the brain by catalase [27, 28] and CYP2E1 [29].
Acetaldehyde may also be responsible for some of the behavioral and physiologi-
cal effects previously attributed to alcohol [30]. For example, when acetaldehyde is 
administered to lab animals, it leads to in-coordination, memory impairment and 
sleepiness effects often associated with alcohol [26]. Deficiency of aldehyde dehy-
drogenase (ALDH2) leads to accumulation of acetaldehyde which results in facial 
flushing or blotches associated with erythema on the face, neck, shoulders, and in 
some cases, the entire body [31].
5.2 Acetate
Oxidation of acetaldehyde produce acetate which is later oxidized to carbon 
dioxide (CO2) in the heart, brain and skeletal muscles. Acetate is also metabolized 
Figure 1. 
Oxidative pathway of alcohol metabolism [17].
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to acetyl CoA, which is involved in lipid and cholesterol biosynthesis in the mito-
chondria of peripheral and brain tissues. Acetate causes depression in the central 
nervous system and also affects various metabolic processes [17].
6. Non-oxidative metabolism
Ethanol is non-oxidatively metabolized by two pathways; first reaction is cata-
lyzed by the enzyme fatty acid ethyl ester (FAEE) synthase leads to the formation of 
molecules known as FAEEs. In the second pathway, reaction with the enzyme phos-
pholipase D (PLD) results in the formation of a phospholipid known as phosphatidyl 
ethanol [32]. This pathway is a critical component in cellular communication.
Alcohol metabolism involves both oxidative and non-oxidative inter related path-
ways. When ethanol oxidation is inhibited through enzyme inhibition, non-oxidative 
metabolism is increased along with increase in FAEEs in the liver and pancreas [33].
7. The genetics of alcohol metabolism
Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) are the 
main enzymes of alcohol metabolism. Both the enzymes have several forms encoded 
by different genes. Enzymes with different characteristics having different ethnic 
distributions are because of variants of these genes. Since these enzyme variants work 
efficiently than others suggesting some people can metabolize alcohol more quickly, 
for example, a fast ADH enzyme or a slow ALDH enzyme may increase acetaldehyde 
level resulting in deleterious health effects including alcohol dependence [34].
A null allele is a mutant copy of a gene at a locus that completely lack normal 
function. This can result in to complete absence of the gene product (protein, 
RNA), or the expression of a non-functional gene product. At the phenotypic level, 
a null allele is indistinguishable from a deletion of the entire locus [35].
Because of genetic difference in these enzymes, alcohol related problems are 
either higher or lower in some ethnic groups, for example, ADH1B*2, a variant of 
ADH is common in people of China, Japan and Korea but rare in Europe and Africa 
[36]. Another version of the ADH enzyme ADH1B*3, occurs in 15–25% of African 
Americans [37]. These enzymes protect against alcoholism [38] by elevating the 
level of acetaldehyde that make drinking unpleasant [39]. Two variations of the 
ALDH enzyme, ALDH1A1*2 and ALDH1A1*3, may be associated with alcoholism in 
African-American people [40].
Along with genetic factors, environmental factors are also important for alcohol-
ism and alcohol-related health problems, for example, alcohol consumption increased 
from 2.5 to 13% in Japanese alcoholics who carried the protective ADH1B*2 gene [41]. 
There is no difference in the rate of alcohol metabolism and enzyme pattern between 
Native Americans and Whites, more Native American people die of alcoholism than 
any other ethnic group in the United States [42]. This suggests that a rate of alcohol-
ism and alcohol-related problems depends on environmental and genetic factors.
8. Genetic polymorphism
8.1 Alcohol dehydrogenase (ADH)
The major pathway of oxidative metabolism of ethanol in the liver involves ADH 
present in the cytosol. During oxidation an electron carrier nicotinamide adenine 
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dinucleotide (NAD) is reduced to NADH providing reduced cytosolic environment 
in the liver cells. Because of byproduct like highly reactive and toxic free radicals 
and acetaldehyde, the liver cells become more vulnerable to damage [17]. Control of 
ADH activity is complex and involves: (a) dissociation of the product NADH which 
is a rate limiting step and (b) product inhibition by NADH and acetaldehyde [14].
ADH comprises of a complex family. In humans on the basis of kinetic and 
structural properties, enzyme ADH has been categorized into five classes. Most of 
them are found in liver, stomach and lungs except ADH5 found in most tissues [17]. 
If alcohol concentration is high, it is eliminated at a higher rate because of high 
activity of enzymes viz. class II ADH encoded by ADH4 gene and β3-ADH encoded 
by ADH1B*3 gene [43].
Aldehyde dehydrogenase (ALDH2) rapidly metabolizes acetaldehyde (produced 
by alcohol oxidation) to acetate and NADH. NADH is then oxidized through elec-
tron transport chain, or respiratory chain enzymes [17]. Among various isozymes 
of ALDH, only the cytosolic ALDH1 and the mitochondrial ALDH2 can metabolize 
acetaldehyde [44, 45].
9. Genetic Polymorphism in ADH and ALDH2
9.1 ADH
Genetic polymorphism in ADH1B and ADH1C gene locations is associated with 
different levels of enzyme activity [46]. In different population ADH1B occur 
at different frequencies. For example, in Caucasian and black populations it is 
predominant, whereas in Chinese, Japanese and in some people of Jewish ancestry 
ADH1B*2 frequency is higher. In case of Caucasian populations, ADH1C*1 and 
ADH1C*2 appear with equal frequency [47]. People of Jewish descent carrying 
the ADH1B*2 allele show only marginally (<15%) higher alcohol elimination rates 
compared to people with ADH1B*1. Also, African Americans [48] and native 
Americans with the ADH1B*3 allele metabolize alcohol at a faster rate than those 
with ADH1B*1 [49].
Variants in both ADH and ALDH2 genes can influence alcohol metabolism by 
either increasing turnover of ethanol to acetaldehyde or deactivating oxidization 
function of acetaldehyde to harmless acetic acid [34, 50]. This can result in accumu-
lation of acetaldehyde, which is a known mutagen and carcinogen that cause DNA 
damage and promote esophageal squamous cell carcinoma (ESCC) development 
[51]. In addition, ADH and ALDH2 alleles may influence individual alcohol  
consumption habits and risk of alcoholism development.
Information on alcohol consumption, sex, and family history is essential in risk 
analyses of alcohol-related variants for several reasons. First, alcohol consumption 
could be a strong confounding variable and effect modifier in comparing genotypes 
and the risk of ESCC because genotypes and alcohol consumption are interrelated. 
Second, alcohol-related enzymes do not play a major role in ESCC development 
among alcohol nondrinkers, or females who drink lesser alcohol than males. Also 
the adverse role of loss-of-functional ADH and ALDH variants will increase in 
alcohol drinkers. Third, the mechanism of tumorigenesis may not be same with and 
without a family history of the esophageal cancer [52, 53].
9.2 ALDH
The allelic variants ALDH2*1 and ALDH2*2 resulted from genetic polymor-
phism of ALDH2 gene is inactive showing no acetaldehyde metabolism in vitro. 
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After alcohol consumption level of acetaldehyde is high in people having heterozy-
gous or homozygous condition for ALDH2*2 allele [44, 45] and therefore experience 
negative physiological responses to alcohol.
10. Cytochrome P450
Cytochrome P450 enzymes are present in almost all tissues of the body and 
play important roles in hormone synthesis and breakdown including estrogen and 
testosterone, cholesterol synthesis and vitamin D metabolism. Cytochrome P450 
enzymes also function to metabolize potentially toxic compounds, for example, 
drugs and bilirubin, principally in the liver [54]. The cytochrome P450 isozymes, 
including CYP2E1, 1A2, and 3A4 which are present predominantly in the micro-
somes or endoplasmic reticulum, also contribute to alcohol oxidation in the liver. 
However, CYP2E1 is active only after a person consume large amount of alcohol, 
and catalase metabolizes only a small fraction of alcohol in the body [47]. This 
enzyme is induced when alcohol concentration is high and it metabolizes alcohol 
in to acetaldehyde. It also oxidizes alcohol in tissue like brain where ADH activity 
is low. It produces ROS which increase the risk of tissue damage [17]. When alcohol 
is metabolized by CYP2E1, highly reactive oxygen containing molecules or reactive 
oxygen species (ROS) is produced. ROS can damage proteins and DNA or interact 
with other substances to create carcinogenic compounds [55].
11. Genetic polymorphism in CYP2E1
CYP2E1 enzyme is an important member of the cytochrome P450 family. It is a 
naturally ethanol-inducible enzyme involved in alcohol metabolism. Polymorphism 
in RsaI/PstI in the promoter gene region increases transcriptional activity of the gene 
which may play an important role in the development of esophageal carcinoma [56].
CYP2E1 c1/c1 genotype found at increased risk for gastric cardia cancer (GCC). 
Individuals with this genotype and have a history of heavy cigarette smoking 
were at increased risk for GCC. This suggests that the interaction of the CYP2E1 
polymorphism with smoking has a great influence on susceptibility to GCC [57]. 
Polymorphisms in CYP2E1 involved in the metabolism of carcinogens tobacco and 
alcohol, leads to Head and Neck Squamous Cell Carcinoma (HNSCC). Haplotype 
analysis revealed that haplotype T-A was associated with a greater than 10-fold increase 
in risk for HNSCC. Use of alcohol or tobacco interact with CYP2E1 variant genotypes 
or with GSTM1 or XRCC1 and increases the risk of HNSCC suggest the importance of 
gene–gene and gene–environment interactions in the development of HNSCC [58].
There was no risk of ESCC found associated with CYP2A6, CYP2E1, GSTM1 
polymorphism suggest an opposite role of GSTP1 and GSTT1 polymorphisms for 
ESCC [59]. Gene polymorphism in GSTM1, GSTT1, GSTP1, CYP1A1 and CYP2E1 
represent risk-modifying factors for ethanol related diseases in Brazilian alcoholics 
and controls with similar ethnic backgrounds. Also the persons with these geno-
types are genetically more prone to the development of alcoholic pancreatitis and 
alcoholic cirrhosis, respectively [60–63].
12. Catalase
Catalase (in peroxisomes) is capable of oxidizing ethanol in vitro in the presence 
of a hydrogen peroxide (H2O2) generating system, such as the enzyme complex 
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NADPH oxidase or the enzyme xanthine oxidase. It converts hydrogen peroxide 
into water and molecular oxygen. Quantitatively, however, this is considered a 
minor pathway of alcohol oxidation, except in the fasted state [64].
12.1 Genetic polymorphism in catalase
CAT pathway plays a prominent role in the oxidation of ethanol in the brain [17]. 
A common polymorphism in the promoter region of the catalase gene CAT c.-
262C > T (rs1001179) influences the susceptibility to alcohol dependence and severity 
of alcohol dependence [65]. It was found that CAT levels were significantly higher in 
subjects carrying CAT -262 T allele [66, 67]. There is one study showing CAT  activity 
and alcohol intake are interrelated [68], but the impact of this polymorphism in 
alcohol dependence needs to be investigated for proper conclusions [67].
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